Biden Administration Looks to Expand Access to Covid-19 Antiviral Pills

Officials are reviewing whether Paxlovid, Pfizer’s oral drug awaiting approval, can be made widely available on the commercial market.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept Learn more…